In a regulatory filing, Dentsply Sirona (XRAY) disclosed that its director Gregory Lucier bought 15.1K shares of common stock on March 3rd in a total transaction size of $250K.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Hold Rating Maintained for DENTSPLY SIRONA Amid Market Challenges and Strategic Uncertainty
- DENTSPLY SIRONA’s Mixed Earnings Call Insights
- Dentsply Sirona price target lowered to $20 from $24 at Barrington
- Dentsply Sirona price target lowered to $20 from $22 at Baird
- Dentsply Sirona price target lowered to $19 from $20 at Wells Fargo